This study reports the identification of broadly protective antibodies targeting the influenza B neuraminidase away from its active site. One dose of antibody therapy was more protective in mice than multiple doses of the current standard of care.
- Teddy John Wohlbold
- Kira A. Podolsky
- Florian Krammer
